Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
(Adds BenevolentAI comment)By Emma-Victoria Farr and Paul SandleLONDON, Dec 6 (Reuters) - Amsterdam-listed Odyssey has agreed to buy BenevolentAI in a deal valuing the British-based pharmaceuticals firm at up to 1.5 billion euros after the transac...
Read moreDec 6 (Reuters) - Novartis hopes to still play a role in the development of COVID-19 treatments with research ongoing for a pill that could work broadly against coronaviruses, not just the one that causes COVID-19, chief executive Vas Narasimhan ...
Read more(Adds quotes and details on Omicron)LONDON, Dec 6 (Reuters) - Future pandemics could be even more lethal than COVID-19 so the lessons learned from the outbreak must not be squandered and the world should ensure it is prepared for the next viral on...
Read moreLONDON, Dec 6 (Reuters) - Future pandemics could be even more lethal than COVID-19 so the lessons learned from the pandemic must not be squandered, one of the creators of the Oxford-AstraZeneca vaccine said."This will not be the last time a virus ...
Read more
(Sharecast News) - Hutchmed China announced on Friday that, following negotiations with the China National Healthcare Security Administration (NHSA), from 1 January the updated National Reimbursement Drug List (NRDL) will continue to include 'Elunate', or fruquintinib, and would now include 'Sulanda', or surufatinib.
Read more* Data behind UK booster decision published* Pfizer and Moderna give large antibody, T-cell boosts* Broad T-cell responses give hope of variant protection (Adds reaction, additional study, TV media marker)By Alistair SmoutLONDON, Dec 3 (Reuters) - C...
Read more* Data behind UK booster decision published* Pfizer and Moderna give large antibody, T-cell boosts* Broad T-cell responses give hope of variant protectionBy Alistair SmoutLONDON, Dec 2 (Reuters) - COVID-19 vaccines made by Pfizer and Moderna that us...
Read more* Two cases detected in Karnataka showing mild symptoms* Officials say priority is to fully vaccinate adults first (Adds details on vaccines)BENGALURU, Dec 2 (Reuters) - India reported its first two cases of the Omicron coronavirus variant on Thurs...
Read more* Two cases detected in Karnataka showing mild symptoms* Officials say priority is to fully vaccinate adults first (Adds details of the patients in paragraphs 3-6)By Anuron Kumar Mitra and Chandini MonnappaBENGALURU, Dec 2 (Reuters) - India reported...
Read more(Corrects description to inactivated virus, in paragraph 1)Dec 2 (Reuters) - The European Union's drug regulator said on Thursday it had started a rolling review of the inactivated-virus COVID-19 vaccine from French biotech firm Valneva, weeks aft...
Read more(adds Valneva comment on Omicron variant)Dec 2 (Reuters) - The European Union's drug regulator said on Thursday it had started a rolling review of the protein-based COVID-19 vaccine from French biotech firm Valneva, weeks after the EU signed a dea...
Read more(Sharecast News) - On current evidence, the Omicron variant of Covid-19 did not yet appear to be any deadlier than previous ones, Australian health officials said.
Read more* Sotrovimab, developed with Vir, tested in lab and on hamsters* Key Omicron mutations did not elude drug activity in study* Tests continuing on further mutations (Adds methods, chief scientist's comment)By Ludwig BurgerDec 2 (Reuters) - Laboratory...
Read more* Sotrovimab, developed with Vir, tested in lab and on hamsters* Key Omicron mutations did not elude drug activity in study* Tests continuing on further mutations (Adds background on rival drugs)By Ludwig BurgerDec 2 (Reuters) - Laboratory analysis...
Read moreBy Michael HoldenLONDON, Dec 1 (Reuters) - Britain said on Wednesday it had agreed deals to buy 114 million more Pfizer/BioNTech and Moderna COVID-19 vaccine shots, saying it had sped up signing the new contracts in light of the emergence of the n...
Read more
Last checked at